期刊文献+

脑卒中临床试验设计与实施应注意的若干问题 被引量:5

Cautions in experimental designing and performance on cerebral apoplexy
原文传递
导出
摘要 循证防治实践指根据已有的高质量临床研究证ぞ萁蟹乐魏土俅惭芯?脑血管病循证防治实践显示:在众多疗法中,有充分证据证明有效应该推广的不多,但同时有充分证据证明无效应该淘汰的也很少,多数属于尚无充分证据肯定或否定其疗效,应该进行更多高质量研究这类.另一方面,越来越多的学者注意到脑卒中临床试验的数量并不少,但质量则令人担忧.应当认识到,随机对照试验(RCT)是产生证据的方法或工具,但并非所有"RCT"结果均为可靠证据.临床研究者需要掌握进行高质量临床试验的方法,临床医生则需要具有辨别研究证据质量的能力.了解临床试验方法学进展很有必要.世界上最早关于卒中的RCT发表于1960年[1].之后,对RCT方法的研究进展迅速,其趋势为从小样本到大样本,从单中心到多中心,从复杂化到简单化;疗效判断从局部到整体,从疾病到患者,从短时间到长周期.脑卒中临床试验设计与实施的下列问题值得注意.
作者 刘鸣
出处 《中华神经科杂志》 CAS CSCD 北大核心 2004年第4期289-291,共3页 Chinese Journal of Neurology
  • 相关文献

参考文献11

  • 1Warlow CP, Dennis MS, van Gijn J, et al, eds. Stroke: a practical guide to management. 2nd ed. Oxford:Blackwell Science, 2001.21-23.
  • 2Collins R, Peto R, Gray R, et al. Large-scale randomized evidence:trials and overviews. In: Wetherall DJ, Ledingham JGG, Warrell DA, eds. Oxford Textbook of Medicine. 3rd ed. Oxford: Oxford University Press, 1996.21-32.
  • 3International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomized trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke. Lancet, 1997,349:1569-1581.
  • 4CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST:randomized placebo-controlled trial of early aspirin use in 20 000patients with acute ischaemic stroke. Lancet, 1997,349:1641-1649.
  • 5Warlow CP. Comparing like with like and the development of randomization-goodbye anecdotes. In: Duley L, Farrell B, eds.Clinical Trials. London: BMJ Books, 2002.1-10.
  • 6Lees KR, Hankey GJ, Hacke W. Design of future acute-stroke treatment trials. Lancet Neurol, 2003,2:54-61.
  • 7Sackett DL, Straus SE, Richardson WS, et al. Evidence-based medicine: how to practice and teach EBM. 2nd ed. London:Churchill Livingstone, 2000. 105-252.
  • 8刘鸣,何俐.神经疾病领域循证医学的应用概述[J].中华神经科杂志,2000,33(6):368-370. 被引量:39
  • 9吴波,刘鸣.脑卒中临床试验疗效判定现状及趋势[J].中华神经科杂志,2002,35(3):177-179. 被引量:48
  • 10刘鸣,吴波,袁强.我国急性脑卒中临床试验疗效判断方法分析[J].中国循证医学杂志,2004,4(3):164-166. 被引量:10

二级参考文献18

  • 1Duncan PW, Jorgemen HS, Wade DT. Outcome measures in acute stroke trials: a systematic review and some recommendations to improve practice[J]. Stroke, 2000;31:1 429-1438
  • 2Wade DT. Measurement in Neurological Rehabilitation. Oxford,England: Oxford University Press, 1996
  • 3Roberts L , Counsell C. Assessment of Clinical Outcomes in Acute Stroke Trials[J]. Stroke,1998 ;29:986-991
  • 4Wang JL, editor-in-chief. Linchuang Liuxingbmg Xue-Linchuang Keyan Sheji, Henghang Yu Pingjia [ M ]. 2nd edition.Shanghai: Shanghai Science and Technology Press. 2001王家良主编.临床流行病学--临床科研设计、衡量与评价.第二
  • 5Sally Hollis,Fiona Campbell.What is meant by intention to treat analysis? Survey of published randomised controlled trials[].British Medical Journal.1999
  • 6Roberts L,Counsell C.Assessment of clinical outcomes in acute stroke trials[].Stroke.1998
  • 7Wade DT.Measurement in neurological rehabilitation[]..1992
  • 8Goldstein LB,Samsa GP.Reliability of the national institutes of health stroke scale: extension to non-neurologists in the context of a clinical trial[].Stroke.1997
  • 9van Straten A,De Haan RJ,Limberg M,et al.Clinical meaning of the stroke-adapted sickness impact profile-30 and the sickness impact profile136[].Stroke.2000
  • 10Williams LS,Weinberger M,Harris LE,et al.Development of a strokespecific quality of life scale[].Stroke.1999

共引文献107

同被引文献31

引证文献5

二级引证文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部